Latest news
Evotec stock trades on report context and market data - AD HOC NEWSAD HOC NEWS · Sun, 09 Aug 2026 12:35:20 GMTEvotec AG (NASDAQ:EVO) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeatMarketBeat · Sat, 08 Aug 2026 08:15:49 GMTEvotec and Odyssey Therapeutics enter AI-enabled drug discovery collaboration in autoimmune and inflammatory diseases - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 10:18:54 GMTEvotec, Odyssey Launch R&D Partnership in Autoimmune, Inflammatory Diseases - Contract PharmaContract Pharma · Thu, 06 Aug 2026 19:16:38 GMTEvotec partners with Odyssey Therapeutics on AI-enabled autoimmune, inflammatory drug discovery - BitgetBitget · Thu, 06 Aug 2026 12:18:25 GMTEVO Looks 51.5% Undervalued on GF Value™ Despite Autoimmune Drug Partnership - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:18:11 GMTEvotec and Odyssey Pair AI With Lab Tests for Immune Diseases - Stock TitanStock Titan · Thu, 06 Aug 2026 08:18:30 GMTEvotec Se and Odyssey Therapeutics, Inc. Enter Ai-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 07:20:32 GMT